Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
Active, not recruiting · NCT04503694 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 2 | 2026-05-22 | NCT04503694 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jules Bordet Institute | 39 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AZ Groeninge | Kortrijk | Belgium | 53 |
| Chirec Delta | Brussels | Belgium | 2 |
| CHR Namur | Namur | Belgium | 1 |
| CHU Ambroise Paré | Mons | Belgium | 6 |
| Cliniques Universitaires Saint-Luc | Brussels | Belgium | 147 |
| Grand Hopital de Charleroi | Gilly | Belgium | 1 |
| Institut Jules Bordet | Anderlecht | Belgium | 45 |
| UZ Gent | Ghent | Belgium | 113 |
| UZAntwerpen | Edegem | Belgium | 1 |